M. Turk Et Al. , "A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism," TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3, pp.198-205, 2016
Turk, M. Et Al. 2016. A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3 , 198-205.
Turk, M., Aldag, Y., Oguzulgen, I. K., & Ekim, N., (2016). A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3, 198-205.
Turk, MURAT Et Al. "A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism," TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3, 198-205, 2016
Turk, MURAT Et Al. "A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism." TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3, pp.198-205, 2016
Turk, M. Et Al. (2016) . "A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism." TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.64, no.3, pp.198-205.
@article{article, author={MURAT TÜRK Et Al. }, title={A cost comparison of warfarin vs enoxaparine or new oral anticoagulants used for the treatment of patients with pulmonary embolism}, journal={TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX}, year=2016, pages={198-205} }